Insight into the origin and clonal history of B‐cell tumors as revealed by analysis of immunoglobulin variable region genes

Summary: Recombination of VH DH and JH genes is a unique first step in normal B‐cell development. Subsequent differentiation to a mature plasma cell is accompanied by further events in the Ig genes, including VI‐Jt joining, somatic hypermutation and isotype switching. Chromosomal changes leading to B‐cell tumors can occur at many points in this sequence, and may be partly a consequence of the genetic mobility and mutability permitted in order to generate a diverse antibody repertoire, V genes of neo‐plastic B cells may reflect the point of maturation reached by the B cell of origin, prior to transformation, Analysis of tumors therefore provides useful information on V‐gene patterns in normal B cells, and may add another dimension to classification of B‐cell tumors. Transformation ma)’ also preserve cell populations normally destined to die by apoptosis. Tumor cells arrested in the sire where somatic hypermutation and isotype switch are occurring can still be subject to these processes, and could be influenced by persisting antigen. However, mutation is silenced at the point of exit lo the periphery, leading lo fixed mutational patterns in tumors of mature B cells, V‐gene analysis provides an invaluable tool for understanding the genesis of neoplastic change. It also has a clear clinical relevance in tracking tumor cells, measuring residual disease, and finally in offering the opportunity of developing vaccines for treatment.

[1]  R. Bataille,et al.  VH gene analysis of clonally related IgM and IgG from human lymphoplasmacytoid B-cell tumors with chronic lymphocytic leukemia features and high serum monoclonal IgG. , 1998, Blood.

[2]  J. Banchereau,et al.  In vitro triggering of somatic mutation in human naive B cells. , 1997, Journal of immunology.

[3]  K. Rajewsky,et al.  In Vivo Ablation of Surface Immunoglobulin on Mature B Cells by Inducible Gene Targeting Results in Rapid Cell Death , 1997, Cell.

[4]  K. Rajewsky,et al.  Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Zhu,et al.  DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C. , 1997, Journal of immunology.

[6]  S. Pileri,et al.  Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. , 1997, The New England journal of medicine.

[7]  E L Sonnhammer,et al.  Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. , 1997, Journal of molecular biology.

[8]  D. Wright WHAT IS BURKITT'S LYMPHOMA? , 1997, The Journal of pathology.

[9]  Guido Kroemer,et al.  The proto-oncogene Bcl-2 and its role in regulating apoptosis , 1997, Nature Medicine.

[10]  D. Oscier,et al.  Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. , 1997, Blood.

[11]  R. Brezinschek,et al.  Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. , 1997, The Journal of clinical investigation.

[12]  D. Czerwinski,et al.  Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial. , 1997, Blood.

[13]  A S Perelson,et al.  Somatic mutation leads to efficient affinity maturation when centrocytes recycle back to centroblasts. , 1997, Journal of immunology.

[14]  P. Casali,et al.  Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells. , 1997, Blood.

[15]  K. Rajewsky,et al.  Evidence for a large compartment of IgM-expressing memory B cells in humans. , 1997, Blood.

[16]  S. Holgate,et al.  Pattern of usage and somatic hypermutation in the VH5 gene segments of a patient with asthma: Implications for IgE , 1997, European journal of immunology.

[17]  P. Isaacson,et al.  Ongoing immunoglobulin gene mutations in mantle cell lymphomas , 1997, British journal of haematology.

[18]  J. Banchereau,et al.  Induction of somatic mutation in a human B cell line in vitro. , 1997, Immunity.

[19]  F. Stevenson,et al.  Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells. , 1997, Blood.

[20]  D. Schatz,et al.  Neoteny in Lymphocytes: Rag1 and Rag2 Expression in Germinal Center B Cells , 1996, Science.

[21]  P. Isaacson,et al.  Intestinal dissemination of gastric mucosa-associated lymphoid tissue lymphoma. , 1996, Blood.

[22]  M. Lefranc,et al.  Sequence and evolution of the human germline V lambda repertoire. , 1996, Journal of molecular biology.

[23]  C. Chapman,et al.  VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection. , 1996, Blood.

[24]  P. Gregersen,et al.  Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells. , 1996, The Journal of clinical investigation.

[25]  K. Rajewsky,et al.  Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells , 1996, The Journal of experimental medicine.

[26]  R. Levy,et al.  DNA immunization induces protective immunity against B–cell lymphoma , 1996, Nature Medicine.

[27]  J. Banchereau,et al.  Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome. , 1996, Journal of immunology.

[28]  O. Burrone,et al.  IgM-producing chronic lymphocytic leukemia cells undergo immunoglobulin isotype-switching without acquiring somatic mutations. , 1996, The Journal of clinical investigation.

[29]  C. Chapman,et al.  Tracking of the V4–34 (VH4–21) gene in human tonsil reveals clonal isotype switch events and a highly variable degree of somatic hypermutation , 1996, Clinical and experimental immunology.

[30]  D. Catovsky,et al.  Analysis of clonal rearrangements of the Ig heavy chain locus in acute leukemia. , 1996, Blood.

[31]  J. Banchereau,et al.  Normal human IgD+IgM- germinal center B cells can express up to 80 mutations in the variable region of their IgD transcripts. , 1996, Immunity.

[32]  J. D. Capra,et al.  The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3. , 1996, Journal of molecular biology.

[33]  R. Tubbs,et al.  Immunoglobulin V genes in Reed-Sternberg cells. , 1996, New England Journal of Medicine.

[34]  F. Stevenson,et al.  Ig VH gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance. , 1996, Blood.

[35]  J. Banchereau,et al.  B-chronic lymphocytic leukemias can undergo isotype switching in vivo and can be induced to differentiate and switch in vitro. , 1996, Blood.

[36]  J. Sixbey,et al.  Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2 , 1995, Journal of virology.

[37]  J. Binet,et al.  Analysis of VH gene expression in CD5+ and CD5- B-cell chronic lymphocytic leukemia. , 1995, Blood.

[38]  F. Hsu,et al.  Preferential use of the VH4 Ig gene family by diffuse large-cell lymphoma. , 1995, Blood.

[39]  A. Lichtenstein,et al.  Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity. , 1995, Journal of immunology.

[40]  P. Isaacson,et al.  Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells , 1995, The Journal of experimental medicine.

[41]  C. Milstein,et al.  Targeting of non-lg sequences in place of the V segment by somatic hyper mutation , 1995, Nature.

[42]  S. Mori,et al.  BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. , 1995, Blood.

[43]  R. Hawkins,et al.  Idiotypic DNA Vaccines Against B‐cell Lymphoma , 1995, Immunological reviews.

[44]  P. Speight,et al.  B‐Cell Monoclonality, Epstein Barr Virus, and t(14; 18) in Myoepithelial Sialadenitis and Low‐Grade B‐Cell MALT Lymphoma of the Parotid Gland , 1995, The American journal of surgical pathology.

[45]  L. Dehner Here we go again: a new classification of malignant lymphomas. A viewpoint from the trenches. , 1995, American journal of clinical pathology.

[46]  D. Jong,et al.  Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. , 1995, Blood.

[47]  C. Chapman,et al.  Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity. , 1995, Blood.

[48]  M. Kosaka,et al.  Frequent somatic mutations in D and/or JH segments of Ig gene in Waldenström's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter's syndrome but not in common CLL. , 1995, Blood.

[49]  D. Oscier,et al.  Splenic lymphoma with villous lymphocytes involves B cells with extensively mutated Ig heavy chain variable region genes. , 1995, Blood.

[50]  R. Geha,et al.  Somatic mutation of human immunoglobulin V genes in the X-linked HyperIgM syndrome. , 1995, The Journal of clinical investigation.

[51]  J. Weill,et al.  Hypermutation generating the sheep immunoglobulin repertoire is an antigen-independent process , 1995, Cell.

[52]  G. Kelsoe In situ studies of the germinal center reaction. , 1995, Advances in immunology.

[53]  I. Tomlinson,et al.  The human immunoglobulin VH repertoire. , 1995, Immunology today.

[54]  P. Kirkham,et al.  Antibody structure and the evolution of immunoglobulin V gene segments. , 1994, Seminars in immunology.

[55]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[56]  D. Oscier,et al.  Assessment of the role of clonogenic B lymphocytes in the pathogenesis of multiple myeloma. , 1994, Leukemia.

[57]  P. Casali,et al.  The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. , 1994, Immunology today.

[58]  H. Stein,et al.  Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. , 1994, Blood.

[59]  J. D. Capra,et al.  Analysis of somatic mutation in five B cell subsets of human tonsil , 1994, The Journal of experimental medicine.

[60]  V. Martinelli,et al.  Similar patterns of V kappa gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myeloma. , 1994, Blood.

[61]  G. Dighiero,et al.  The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. , 1994, Immunology today.

[62]  E. Vandenberghe Mantle cell lymphoma. , 1994, Blood reviews.

[63]  K. Offit,et al.  Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. , 1994, Blood.

[64]  R. Hawkins,et al.  Clonal history of a human follicular lymphoma as revealed in the immunoglobulin variable region genes , 1994, British journal of haematology.

[65]  K. Rajewsky,et al.  Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. , 1993, The EMBO journal.

[66]  Z. Oltvai,et al.  Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. , 1993, Seminars in cancer biology.

[67]  B. Ness,et al.  The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell , 1993, The Journal of experimental medicine.

[68]  M. Boccadoro,et al.  Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas , 1993, The Journal of experimental medicine.

[69]  C. Milstein,et al.  Discriminating intrinsic and antigen-selected mutational hotspots in immunoglobulin V genes. , 1993, Immunology today.

[70]  A. Morley,et al.  Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: evidence from the Ig heavy chain gene. , 1993, Blood.

[71]  R. Insel,et al.  Isolation of germinal centerlike events from human spleen RNA. Somatic hypermutation of a clonally related VH6DJH rearrangement expressed with IgM, IgG, and IgA. , 1993, The Journal of clinical investigation.

[72]  T. Logtenberg,et al.  Molecular evolution of the human immunoglobulin E response: high incidence of shared mutations and clonal relatedness among epsilon VH5 transcripts from three unrelated patients with atopic dermatitis , 1993, The Journal of experimental medicine.

[73]  J. Riley,et al.  Structure and physical map of 64 variable segments in the 3′ 0.8–megabase region of the human immunoglobulin heavy–chain locus , 1993, Nature Genetics.

[74]  C. Heirman,et al.  Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. , 1992, Blood.

[75]  J. van Es,et al.  High frequency of somatically mutated IgM molecules in the human adult blood B cell repertoire , 1992, European journal of immunology.

[76]  D. Bahler,et al.  Clonal evolution of a follicular lymphoma: evidence for antigen selection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[77]  D. Gray,et al.  Follicular dendritic cell-dependent adhesion and proliferation of B cells in vitro. , 1992, Journal of immunology.

[78]  R. Schwartz,et al.  Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes. , 1992, The Journal of clinical investigation.

[79]  C. Berek The Development of B Cells and the B‐Cell Repertoire in the Microenvironment of the Germinal Center , 1992, Immunological reviews.

[80]  J. Singer,et al.  Nature of remission in acute myeloid leukemia: more questions than answers. , 1992, Leukemia.

[81]  G. Silverman Human antibody responses to bacterial antigens: studies of a model conventional antigen and a proposed model B cell superantigen. , 1992, International reviews of immunology.

[82]  P. Isaacson,et al.  Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma , 1991, The Lancet.

[83]  M. Nussenzweig,et al.  Trans-splicing as a possible molecular mechanism for the multiple isotype expression of the immunoglobulin gene , 1991, The Journal of experimental medicine.

[84]  A. Zelenetz,et al.  Histologic transformation of follicular lymphoma to diffuse lymphoma represents tumor progression by a single malignant B cell , 1991, The Journal of experimental medicine.

[85]  F. Blattner,et al.  Immunoglobulin D switching can occur through homologous recombination in human B cells , 1990, Molecular and cellular biology.

[86]  P. Isaacson Lymphomas of mucosa‐associated lymphoid tissue (MALT) , 1990, Histopathology.

[87]  I. Magrath The pathogenesis of Burkitt's lymphoma. , 1990, Advances in cancer research.

[88]  I. Maclennan,et al.  Mechanism of antigen-driven selection in germinal centres , 1989, Nature.

[89]  A. George,et al.  Prospects for the treatment of B cell tumors using idiotypic vaccination. , 1989, International reviews of immunology.

[90]  G. Inghirami,et al.  Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. , 1988, Blood.

[91]  M. Lipinski,et al.  Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. , 1987, Journal of immunology.

[92]  J. Sklar,et al.  Somatic Mutation in Human B‐Cell Tumors , 1987, Immunological reviews.

[93]  S. Raimondi,et al.  Biologic and prognostic significance of the presence of more than two mu heavy-chain genes in childhood acute lymphoblastic leukemia of B precursor cell origin. , 1986, Blood.

[94]  T. Manser,et al.  Somatic evolution of variable region structures during an immune response. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[95]  N. Maizels,et al.  The T-cell-independent immune response to the hapten NP uses a large repertoire of heavy chain genes , 1985, Cell.

[96]  C. Croce,et al.  Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.